Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
182 Highly potent fully human anti-VISTA antibodies – a new target checkpoint inhibitor against immunosuppressive myeloid cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
